Related Experiment Video
Updated: May 10, 2026

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
Published on: April 3, 2026
Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study
Turan Erdoğan1, Sinan Altan Kocaman, Mustafa Çetin
1Departments of Cardiology, Faculty of Medicine, Rize University, Rize-Turkey. sinanaltan@gmail.com.
Insights
YKL-40 levels are significantly higher in patients with coronary artery ectasia (CAE) compared to normal arteries. This inflammatory marker, YKL-40, was identified as the sole determinant of CAE, suggesting its potential role in the condition.
Area of Science:
- Cardiology
- Biomarkers
- Inflammation
Background:
- Coronary artery ectasia (CAE) has an unclear cause, potentially linked to intense inflammation.
- YKL-40 is an inflammatory biomarker secreted by macrophages in atherosclerotic plaques.
Purpose of the Study:
- To investigate YKL-40 and C-reactive protein (CRP) levels in patients with isolated CAE.
- Compare these levels against patients with normal coronary arteries (NCA) and coronary artery disease (CAD).
Main Methods:
- Observational, cross-sectional study design.
- Included 49 patients with isolated CAE, 30 with NCA, and 30 with CAD.
- Analyzed YKL-40 and CRP levels using univariate and multiple logistic regression.
Main Results:
- Serum YKL-40 levels were significantly higher in CAE (144±68 μg/L) and CAD (180±117 μg/L) groups compared to the NCA group (110±53 μg/L).
- C-reactive protein (CRP) levels did not differ significantly among the groups.
- Logistic regression identified YKL-40 level as the sole determinant of CAE (OR: 1.010, p=0.027).
Conclusions:
- Patients with isolated CAE exhibit significantly elevated YKL-40 levels compared to those with NCA.
- YKL-40 is established as the independent determinant of CAE.
- Further research is warranted to elucidate the causative role of YKL-40 in isolated CAE.
Objective:
YKL-40, a new biomarker of localized inflammation, is secreted by macrophages within the atherosclerotic plaques. Coronary artery ectasia (CAE) is a clinical entity with unclear etiopathogenesis. Some studies have revealed that CAE may be a form of atherosclerosis that has more localized and intense inflammatory properties than atherosclerosis. The goal of this study was to investigate YKL-40 and C-reactive protein (CRP) levels in patients with isolated CAE compared to patients with normal coronary arteries (NCA) and coronary artery disease (CAD).
Methods:
Our study has an observational and cross-sectional design. Forty-nine patients with isolated CAE (mean age: 60±10 years), 30 age-and gender-matched control participants with NCA (30 patients, mean age: 58±12 years) and 30 patients with CAD (mean age: 61±10 years), were included in the study. The relationship between YKL-40, CRP levels and the presence of CAE was investigated. Univariate and multiple logistic regression analysis were used for analysis of independent variables to predict CAE.
Results:
Serum YKL-40 levels were significantly different among study groups (NCA: 110±53 μg/L, CAE: 144±68 and CAD: 180±117, p=0.005). CAD group and CAE group had significantly higher YKL-40 levels than NCA group (p=0.004 and p=0.015, respectively). CRP was not significantly different between three groups. In addition, there were no any statistically significant differences, with respect to age, gender, the presence of hypertension or diabetes mellitus, and the smoking status (p>0.05). Logistic regression analysis revealed only YKL-40 level as the determinant of CAE (OR: 1.010, 95% CI: 1.001-1.019, p=0.027).
Conclusion:
YKL-40 levels in patients with isolated CAE compared to patients with NCA were found significantly high and only YKL-40 level was established as the determinant of CAE. We believe that further studies are needed to clarify the possible causative roles of YKL-40 in patients with isolated CAE.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
